Drug Lists 101 – Supporting Access to Safe and Effective Medications
Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreCoupling Cancer Diagnosis and Treatment with Behavioral Health Care Can Improve Health Outcomes for Oncology Patients
Being diagnosed and living with cancer can cause significant psychological stress.
Read MoreExpress Scripts Introduces New Option to Give Clients Maximum Simplicity in Drug Pricing
Express Scripts ClearNetwork offers employers and health plans a new option for simple, “cost-plus” pharmacy pricing for brand, generic, and specialty medications.
Read MoreClinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreWhat to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read MoreLeveraging biosimilars to drive savings and support patient access
By the end of 2023, 11 biosimilars for Humira will be available for patients living with inflammatory conditions, enabling lower costs for a drug class that currently represents nearly 25% of total dr...
Read More